RANDOMISED STUDY OF EPIDURAL VS MPCA MORPHINE VS TAPP IN LAPAROSCOPIC SIGMOIDECTOMY

RANDOMISED STUDY ABOUT POTSOTERATORY PAIN CONTROL IN LAPAROSCOPIC SIGMOIDECTOMY

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01825993

Acronym

2013/004

Enrollment

225

Registered

2013-04-08

Start date

2013-04-30

Completion date

2015-04-30

Last updated

2013-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sigmoidal Tumour

Keywords

Peridural catheter, Morphine PCA, Transabdominal Block, laparoscopic sigmoidectomy

Brief summary

The investigators would study the control of postoperative pain with peridural catheter, morphine PCA ev or Transabdominal block.

Interventions

DRUGL-BUPIVACAINE ; MORPHINE

DRUGMORPHINE

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Age more than 18 * Laparoscopic sigmoidectomy * Informed consent firmed

Exclusion criteria

* ASA IV * Urgent surgery * Sigmoid tumour stage IV * Cronic pain treatment * No informed consent firmed * Paliative surgery

Design outcomes

Primary

Measure	Time frame	Description
EVA (POSTOPERATIVE PAIN)	72 H POSTOPERATIVE	The investigators asked the patient the postoperative pain during teh first 72 hours by EVA scale.

Secondary

Measure	Time frame	Description
ADVERSE EFFECTS	five days	the investigators look for adverse effects

Countries

Spain

Contacts

Primary ContactMORA L. LAURA, MD

Lmora@tauli.cat34937231010

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026